Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Bowel Colorectal Cancer

Follow-up colonoscopy cuts bowel cancer cases in some people

Follow-up tests after an initial colonoscopy may reduce the number of people diagnosed with bowel cancer, according to a new study.

One-off bowel scope cuts cancer risk for at least 17 years

A one-off bowel screening test reduces the risk of developing bowel cancer by more than one third and could save thousands of lives.

More support needed for GPs to make best use of cancer preventing drugs

A new Cancer Research UK report reveals that GPs want more support when offering drugs that lower the risk of certain cancers.

Cancer Research UK and Channel 4 to broadcast world’s first TV advert live from inside the human body

A 90 second advert on 18 January will give viewers a unique opportunity to see live inside the human body

Welsh government to introduce improved screening tests for cervical and bowel cancers

The Welsh government has announced “hugely positive” changes to its screening programmes for both cervical and bowel cancer.

Researchers find key to drug resistant bowel cancer

Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the NCRI Cancer Conference.

Men with a high genetic chance of bowel cancer could have lower risk with healthy lifestyles

Men with a high genetic risk of bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle.

1 in 5 emergency bowel cancer patients had symptoms before diagnosis

Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ leading up to diagnosis.

Vitamin A may help control some cases of bowel cancer

A molecule produced from vitamin A may help protect against some cases of bowel cancer.

Analysis of tumour DNA from blood could predict bowel cancer recurrence

An experimental DNA test could help predict which early-stage bowel cancer patients are at a greater risk of their disease returning following surgery.

Pages